Top Markets
Coin of the day
PlexBio Co., Ltd. PlexBio Co., Ltd.

PlexBio Co., Ltd.

6572
Clasificación en acciones #28557
PlexBio Co., Ltd. is dedicated to the creation and production of in vitro... PlexBio Co., Ltd. is dedicated to the creation and production of in vitro diagnostic (IVD) solutions for both molecular biology and immunology purposes. Their comprehensive product range features services for optimizing diagnostic workflows, as well as automated kits for sample preparation and extraction. A key innovation is their IntelliPlex platform, which leverages pCode technology to enable advanced, "sample-to-answer" multiplexing assays. The company also supplies specialized oncology panels designed for detecting lung cancer, gene mutations, and chromosomal rearrangements. Additionally, PlexBio offers a variety of infectious disease tests, including IntelliPlex kits for SARS-CoV-2 detection, influenza, and SARS-CoV-2 variant analysis, complemented by essential reagents such as pCode coupling buffer sets. Founded in 2009, PlexBio Co., Ltd. operates from its headquarters in Taipei, Taiwan.
Precio por acción
$0.24898639
Capitalización bursátil
$25.81M
Cambio (1 día)
8.00%
Cambio (1 año)
-24.39%
País
TW
Comercio PlexBio Co., Ltd. (6572)

Categoría

Ganancias de PlexBio Co., Ltd. (6572)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di PlexBio Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de PlexBio Co., Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH